Researcher profile
Mary Kathryn Dahlgren
Affiliations
Organizations
Public evidence
3 connected articles
Clinical and Cognitive Improvement Following Treatment with a Hemp-Derived, Full-Spectrum, High-Cannabidiol Product in Patients with Anxiety: An Open-Label Pilot Study.2025 · Europe PMCIncreased White Matter Coherence Following Three and Six Months of Medical Cannabis Treatment.2022 · PubMed Central Open AccessClinical and cognitive improvement following full-spectrum, high-cannabidiol treatment for anxiety: open-label data from a two-stage, phase 2 clinical trial.2022 · PubMed Central Open Access
Matched by exact identifiers only. Profile data: Corpus/OpenAlex.